Susquehanna International Group, LLP Immunocore Holdings PLC Put Options Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$30.06 - $41.49 $6.13 Million - $8.46 Million	203,900 New	203,900 $6.35 Million
Q1 2024 May 07, 2024	BUY	$60.14 - $75.36 $216,504 - $271,296	3,600 Added 15.65%	26,600 $1.73 Million
Q4 2023 Feb 14, 2024	BUY	$42.85 - $69.5 $985,550 - $1.6 Million	23,000 New	23,000 $1.57 Million
Q2 2023 Aug 11, 2023	SELL	$48.54 - $61.64 $354,342 - $449,972	-7,300 Reduced 14.23%	44,000 $2.64 Million
Q1 2023 May 16, 2023	BUY	$46.12 - $65.71 $668,740 - $952,794	14,500 Added 39.4%	51,300 $2.54 Million
Q4 2022 Feb 14, 2023	SELL	$45.51 - $65.08 $3.08 Million - $4.4 Million	-67,600 Reduced 64.75%	36,800 $2.1 Million
Q3 2022 Nov 14, 2022	BUY	$37.34 - $57.44 $545,164 - $838,624	14,600 Added 16.26%	104,400 $4.9 Million

141

41.4M

197K

451K

Ticker IMCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,897,100
Market Cap $1.39B
Description
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.